Artin Bioscience develops therapeutics for respiratory diseases.
Artin Bioscience has raised $483K in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Artin Bioscience is headquartered in Denver, United States.
Artin Bioscience develops therapeutics for respiratory diseases.
Artin Bioscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artin Bioscience — Funding & Investors." VCBacked, March 10, 2023, https://www.vcbacked.co/company/artin-bioscience. Accessed August 14, 2026.
VCBacked. (2023). Artin Bioscience — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/artin-bioscience
{{cite web |title=Artin Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/artin-bioscience |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated